Bruce A Sullenger (Bruce Sullenger)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 23

Top Topics

Magnetic Nanoparticles

Photodynamic Therapy

Top Venues

Nucleic acid therapeutics

Proceedings of the National Academy of Sciences of the United States of America

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Martin D Requena, Amy Yan, Telmo Llanga, Bruce A Sullenger
Reversible Aptamer Staining, Sorting, and Cleaning of Cells (Clean FACS) with Antidote Oligonucleotide or Nuclease Yields Fully Responsive Cells. Nucleic acid therapeutics 34 (1) (2024)
Vladimir N Kolyadko, Juliana M Layzer, Kay Perry, Bruce A Sullenger, Sriram Krishnaswamy
An RNA aptamer exploits exosite-dependent allostery to achieve specific inhibition of coagulation factor IXa. Proceedings of the National Academy of Sciences of the United States of America 121 (29) (2024)
Martin D Requena, Amy Yan, Telmo Llanga, Bruce A Sullenger
Reversible Aptamer Staining, Sorting, and Cleaning of Cells (Clean FACS) with Antidote Oligonucleotide or Nuclease Yields Fully Responsive Cells. Nucleic acid therapeutics 34 (1) (2024)
Vladimir N Kolyadko, Juliana M Layzer, Kay Perry, Bruce A Sullenger, Sriram Krishnaswamy
An RNA aptamer exploits exosite-dependent allostery to achieve specific inhibition of coagulation factor IXa. Proceedings of the National Academy of Sciences of the United States of America 121 (29) (2024)
Ou-Yang Chen, Chang-Yu Jiang, Temugin Berta, Bethany Powell Gray, Kenta Furutani, Bruce A Sullenger, Ru-Rong Ji
MicroRNA let-7b enhances spinal cord nociceptive synaptic transmission and induces acute and persistent pain through neuronal and microglial signaling. Pain 165 (8) (2024)
Martin D Requena, Amy Yan, Telmo Llanga, Bruce A Sullenger
Reversible Aptamer Staining, Sorting, and Cleaning of Cells (Clean FACS) with Antidote Oligonucleotide or Nuclease Yields Fully Responsive Cells. Nucleic acid therapeutics 34 (1) (2024)
Vladimir N Kolyadko, Juliana M Layzer, Kay Perry, Bruce A Sullenger, Sriram Krishnaswamy
An RNA aptamer exploits exosite-dependent allostery to achieve specific inhibition of coagulation factor IXa. Proceedings of the National Academy of Sciences of the United States of America 121 (29) (2024)
Ou-Yang Chen, Chang-Yu Jiang, Temugin Berta, Bethany Powell Gray, Kenta Furutani, Bruce A Sullenger, Ru-Rong Ji
MicroRNA let-7b enhances spinal cord nociceptive synaptic transmission and induces acute and persistent pain through neuronal and microglial signaling. Pain 165 (8) (2024)
Ou-Yang Chen, Chang-Yu Jiang, Temugin Berta, Bethany Powell Gray, Kenta Furutani, Bruce A Sullenger, Ru-Rong Ji
MicroRNA let-7b enhances spinal cord nociceptive synaptic transmission and induces acute and persistent pain through neuronal and microglial signaling. Pain 165 (8) (2024)
Martin D Requena, Amy Yan, Telmo Llanga, Bruce A Sullenger
Reversible Aptamer Staining, Sorting, and Cleaning of Cells (Clean FACS) with Antidote Oligonucleotide or Nuclease Yields Fully Responsive Cells. Nucleic acid therapeutics 34 (1) (2024)
Martin D Requena, Amy Yan, Telmo Llanga, Bruce A Sullenger
Reversible Aptamer Staining, Sorting, and Cleaning of Cells (Clean Fluorescent Activated Cell Sorting) with Antidote Oligonucleotide or Nuclease Yields Fully Responsive Cells. Nucleic acid therapeutics (2024)
Martin D Requena, Amy Yan, Telmo Llanga, Bruce A Sullenger
Reversible Aptamer Staining, Sorting, and Cleaning of Cells (Clean FACS) with Antidote Oligonucleotide or Nuclease Yields Fully Responsive Cells. Nucleic acid therapeutics 34 (1) (2024)
Vladimir N Kolyadko, Juliana M Layzer, Kay Perry, Bruce A Sullenger, Sriram Krishnaswamy
An RNA aptamer exploits exosite-dependent allostery to achieve specific inhibition of coagulation factor IXa. Proceedings of the National Academy of Sciences of the United States of America 121 (29) (2024)
Ou-Yang Chen, Chang-Yu Jiang, Temugin Berta, Bethany Powell Gray, Kenta Furutani, Bruce A Sullenger, Ru-Rong Ji
MicroRNA let-7b enhances spinal cord nociceptive synaptic transmission and induces acute and persistent pain through neuronal and microglial signaling. Pain 165 (8) (2024)
Ou-Yang Chen, Chang-Yu Jiang, Temugin Berta, Bethany Powell Gray, Kenta Furutani, Bruce A Sullenger, Ru-Rong Ji
MicroRNA let-7b enhances spinal cord nociceptive synaptic transmission and induces acute and persistent pain through neuronal and microglial signaling. Pain (2024)
Xirui Song, Haixiang Yu, Cynthia Sullenger, Bethany Powell Gray, Amy Yan, Linsley Kelly, Bruce A Sullenger
An Aptamer That Rapidly Internalizes into Cancer Cells Utilizes the Transferrin Receptor Pathway. Cancers 15 (8) (2023)
Xirui Song, Haixiang Yu, Cynthia Sullenger, Bethany Powell Gray, Amy Yan, Linsley Kelly, Bruce A Sullenger
An Aptamer That Rapidly Internalizes into Cancer Cells Utilizes the Transferrin Receptor Pathway. Cancers 15 (8) (2023)
Susan M Shea, Kimberly A Thomas, Rassam M G Rassam, Emily P Mihalko, Christina Daniel, Bruce A Sullenger, Philip C Spinella, Shahid M Nimjee
Dose-Dependent Von Willebrand Factor Inhibition by Aptamer BB-031 Correlates with Thrombolysis in a Microfluidic Model of Arterial Occlusion. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Susan M Shea, Kimberly A Thomas, Rassam M G Rassam, Emily P Mihalko, Christina Daniel, Bruce A Sullenger, Philip C Spinella, Shahid M Nimjee
Dose-Dependent Von Willebrand Factor Inhibition by Aptamer BB-031 Correlates with Thrombolysis in a Microfluidic Model of Arterial Occlusion. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Susan M Shea, Kimberly A Thomas, Rassam M G Rassam, Emily P Mihalko, Christina Daniel, Bruce A Sullenger, Philip C Spinella, Shahid M Nimjee
Dose-Dependent Von Willebrand Factor Inhibition by Aptamer BB-031 Correlates with Thrombolysis in a Microfluidic Model of Arterial Occlusion. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Susan M Shea, Kimberly A Thomas, Rassam M G Rassam, Emily P Mihalko, Christina Daniel, Bruce A Sullenger, Philip C Spinella, Shahid M Nimjee
Dose-Dependent Von Willebrand Factor Inhibition by Aptamer BB-031 Correlates with Thrombolysis in a Microfluidic Model of Arterial Occlusion. Pharmaceuticals (Basel, Switzerland) 15 (12) (2022)
Jacob T Heggestad, David S Kinnamon, Lyra B Olson, Jason Liu, Garrett Kelly, Simone A Wall, Solomon Oshabaheebwa, Zachary Quinn, Cassio M Fontes, Daniel Y Joh, Angus M Hucknall, Carl F Pieper, Jack G Anderson, Ibtehaj A Naqvi, Lingye Chen, Loretta G Que, Thomas H Oguin, Smita K Nair, Bruce A Sullenger, Christopher W Woods, Thomas W Burke, Gregory D Sempowski, Bryan D Kraft, Ashutosh Chilkoti
Multiplexed, quantitative serological profiling of COVID-19 from blood by a point-of-care test. Science advances 7 (26) (2021)
Jacob T Heggestad, Rhett J Britton, David S Kinnamon, Simone A Wall, Daniel Y Joh, Angus M Hucknall, Lyra B Olson, Jack G Anderson, Anna Mazur, Cameron R Wolfe, Thomas H Oguin, Bruce A Sullenger, Thomas W Burke, Bryan D Kraft, Gregory D Sempowski, Christopher W Woods, Ashutosh Chilkoti
Rapid test to assess the escape of SARS-CoV-2 variants of concern. Science advances 7 (49) (2021)